Skip to search formSkip to main contentSkip to account menu

androgen replacement therapy

Known as: androgens replacement therapy 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
The adequate criteria for late-onset hypogonadism (LOH) diagnosis, including serum testosterone levels, type (total or free… 
2014
2014
A 53-year-old man presented to our hospital with a few-month history of fatigue and anorexia. His aging male's symptoms (AMS… 
Review
2013
Review
2013
Late-onset hypogonadism (LOH) is defined as the condition caused by the decline of testosterone by aging, along with various… 
Review
2013
Review
2013
Prostate cancer has the highest incidence in the United States and the second highest in the world among cancers in the male… 
2011
2009
2009
We examined the effects of androgen replacement therapy (ART) on scores of a comprehensive health-related quality of life (HR-QOL… 
2009
2009
A specialized clinic for middle-aged and elderly hypogonadal men was established in our institution five years ago. A… 
2004
2004
Hypogonadism, especially in aging men, is being identified and treated more frequently. Androgen replacement therapy began in the… 
2002
2002
AIM In 11 congenital hypogonadal men, the bone mineral density (BMD) values were determined to assess the effect of long-term… 
Review
1999
Review
1999
Androgen replacement therapy (ART) in postmenopausal women is controversial, in part because the role androgens play in women is…